How have CO shares performed in 2024?

Global Cord Blood's stock was trading at $1.22 at the beginning of 2024. Since then, CO stock has increased by 2.5% and is now trading at $1.25. View the best growth stocks for 2024 here .

How were Global Cord Blood's earnings last quarter?

Global Cord Blood Co. (NYSE:CO) issued its earnings results on Tuesday, June, 26th. The medical research company reported $0.04 earnings per share for the quarter, missing the consensus estimate of $0.13 by $0.09. The medical research company had revenue of $37.14 million for the quarter.

Is Global Cord Blood a good dividend stock?

Global Cord Blood (NYSE:CO) pays an annual dividend of $0.08 per share and currently has a dividend yield of 0.00%. The dividend payout ratio is 12.50%. This payout ratio is at a healthy, sustainable level, below 75%. Read our dividend analysis for CO .

What other stocks do shareholders of Global Cord Blood own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Global Cord Blood investors own include AbbVie (ABBV) , Fate Therapeutics (FATE) , Gilead Sciences (GILD) , Rigel Pharmaceuticals (RIGL) , Spero Therapeutics (SPRO) , Vertex Pharmaceuticals (VRTX) , Enphase Energy (ENPH) , Galectin Therapeutics (GALT) , Intel (INTC) and Marvell Technology (MRVL) .

How do I buy shares of Global Cord Blood?

Shares of CO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NYSE:CO

Global Cord Blood (CO) Stock Price, News & Analysis

→ You’re invited: Biggest crypto event of 2024 (From InvestorPlace) (Ad)

Free CO Stock Alerts

$1.25

0.00 (0.00%)

(As of 04/17/2024 ET)

Compare

Today's Range: $1.25
▼
$1.25
50-Day Range: $1.25
▼
$2.00
52-Week Range: $2.03
▼
$5.50

Volume: 50 shs
Average Volume: 216,519 shs
Market Capitalization: $151.94 million

P/E Ratio: 1.95
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Competitors Financials Headlines Ownership SEC Filings Social Media

Get Global Cord Blood alerts:

Ad DTI

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

About Global Cord Blood Stock (NYSE:CO)

Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. It provides cord blood processing and storage service. The company also offers cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The firm preserves cord blood units donated by the public and provides matching services on such donated units and deliver matching units to patients in need of transplants. Global Cord Blood was founded on January 17, 2008 and is headquartered in Hong Kong.

CO Stock Price History

30 days | 90 days | 365 days | Advanced Chart

CO Stock News Headlines

April 17, 2024 | msn.com

Nigeria rolls out world's first full shot against meningitis: Here's what you need to know

April 17, 2024 | finance.yahoo.com

Blood Collection Market size worth $ 14.76 Billion, Globally, by 2031 at 5.10% CAGR – Report By Verified Market Research®

April 19, 2024 | InvestorPlace (Ad)

You’re invited: Biggest crypto event of 2024

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

April 16, 2024 | finance.yahoo.com

NMDP BioTherapies Introduces Enhanced Cellular Materials for Allogeneic Cell Therapy Development

April 15, 2024 | msn.com

WHO spokesperson raises concerns over growing threat of mosquito-borne illness: 'Their detection by healthcare systems [is] quite challenging'

April 12, 2024 | americanbankingnews.com

StockNews.com Begins Coverage on Global Cord Blood (NYSE:CO)

April 11, 2024 | finance.yahoo.com

Global Voice Prosthesis Devices Market Size To Worth USD 2.29 Billion By 2033 | CAGR of 5.51%

April 4, 2024 | msn.com

Mark Ruffalo on the ‘evil’ company that poisoned every person on the planet – then kept it secret

April 19, 2024 | InvestorPlace (Ad)

You’re invited: Biggest crypto event of 2024

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

April 3, 2024 | msn.com

EXPLAINER: What you need to know about Tuberculosis

April 3, 2024 | msn.com

Surgical objects were mistakenly left in the bodies of more than 200 Philly-area patients over six years. The error is rare, but it can be catastrophic.

April 3, 2024 | msn.com

Reasons for Poor Performance in Nairobi Children - Study

March 28, 2024 | msn.com

Gaza conflict is creating a traumatised generation of child amputees, warn medics

March 28, 2024 | sg.finance.yahoo.com

OKX’s Global Compliance Chief Left After Six Months

March 28, 2024 | msn.com

Preparing for an allergic reaction

March 20, 2024 | finance.yahoo.com

Biobanking Market Outlook Forecast 2024-2029 - Virtual Biobanks Are Gaining Popularity

March 18, 2024 | msn.com

London-bound flight from Bangkok makes emergency landing after passenger's suspected suicide attempt

March 18, 2024 | finance.yahoo.com

Cell Cryopreservation Market Forecast 2024-2029: Europe Set to Command Significant Share Amid Increasing Scientific Advancements

March 15, 2024 | msn.com

How Safe Are Covid Vaccines? Here’s What We Know Now

March 15, 2024 | msn.com

ICSE Class 10 Biology Question Paper 2023 Solved PDF, Check Important Questions and Answers for Last Minute Revision

March 14, 2024 | msn.com

'Victorian' disease which killed millions now at worldwide high again - these are the symptoms

March 13, 2024 | businesswire.com

Sangamo Therapeutics Announces Data From Novel Proprietary Neurotropic AAV Capsid Demonstrating Industry-leading Blood-brain Barrier Penetration and Brain Transduction in NHPs

March 13, 2024 | finance.yahoo.com

Fetal Monitoring Market revenue to reach USD 15.81 Billion by 2035, says Research Nester

March 11, 2024 | markets.businessinsider.com

Brain Canada Celebrates Brain Health Awareness Month with Boost your Brain Awareness Campaign

March 9, 2024 | mirror.co.uk

Desperate families lives are saved by strangers they've never met - delighted mums speak out

February 28, 2024 | msn.com

'I wouldn’t be here without it': Baby's umbilical cord donation saved Emma's life

February 28, 2024 | finance.yahoo.com

Global Biobanking Market Report 2024: Market Set to Surpass $75 Billion in 2024, Growing Demand for Umbilical Cord Blood Banking

See More Headlines

Receive CO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Global Cord Blood and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 6/26/2018
Today: 4/18/2024
Fiscal Year End: 3/31/2025

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Sector: Medical
Industry: Miscellaneous health & allied services, not elsewhere classified
Sub-Industry: N/A
Current Symbol: NYSE:CO
CUSIP: N/A
CIK: 1467808
Web: www.globalcordbloodcorp.com
Phone: (523) 605-8180
Fax: 852-3605-8181
Employees: 1,202
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: 1.95
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: $1.24 billion
Price / Sales: 0.12
Cash Flow: $0.30 per share
Price / Cash Flow: 4.19
Book Value: $6.34 per share
Price / Book: 0.20

Miscellaneous

Outstanding Shares: 121,551,000
Free Float: N/A
Market Cap: $151.94 million
Optionable: No Data
Beta: 0.16

A Guide To High-Short-Interest Stocks

MarketBeat's analysts have just released their top five short plays for April 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

Ting Zheng
Chairman & Chief Executive Officer
Bing Chuen Chen
Chief Financial Officer & Director
Xin Xu
Chief Technology Officer
Rui Arashiyama
CEO-Guangdong & Zhejiang Divisions

Key Competitors

View All Competitors

CO Stock Analysis - Frequently Asked Questions

How have CO shares performed in 2024?: Global Cord Blood's stock was trading at $1.22 at the beginning of 2024. Since then, CO stock has increased by 2.5% and is now trading at $1.25.
View the best growth stocks for 2024 here.
How were Global Cord Blood's earnings last quarter?: Global Cord Blood Co. (NYSE:CO) issued its earnings results on Tuesday, June, 26th. The medical research company reported $0.04 earnings per share for the quarter, missing the consensus estimate of $0.13 by $0.09. The medical research company had revenue of $37.14 million for the quarter.
Is Global Cord Blood a good dividend stock?: Global Cord Blood (NYSE:CO) pays an annual dividend of $0.08 per share and currently has a dividend yield of 0.00%. The dividend payout ratio is 12.50%. This payout ratio is at a healthy, sustainable level, below 75%.
Read our dividend analysis for CO.

What other stocks do shareholders of Global Cord Blood own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Global Cord Blood investors own include AbbVie (ABBV), Fate Therapeutics (FATE), Gilead Sciences (GILD), Rigel Pharmaceuticals (RIGL), Spero Therapeutics (SPRO), Vertex Pharmaceuticals (VRTX), Enphase Energy (ENPH), Galectin Therapeutics (GALT), Intel (INTC) and Marvell Technology (MRVL).
How do I buy shares of Global Cord Blood?: Shares of CO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:CO) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Global Cord Blood (CO) Stock Price, News & Analysis

About Global Cord Blood Stock (NYSE:CO)

CO Stock Price History

CO Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

CO Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info